or Try an Advanced Search...

    Continuous Glucose Monitor Stocks List

    Symbol Grade Name % Change
    DXCM A DexCom, Inc. 0.10
    SENS F Senseonics Holdings, Inc. -3.42
    NMRD F Nemaura Medical Inc. -12.77
    View As Page of Charts
    Related Industries: Diagnostics & Research Medical Devices
    Related Stock Lists: Blood Glucose Monitoring Diabetes Diabetes Mellitus Glucose Medical Monitoring Medicine Blood Test Endocrine System Endocrinology Glucose Monitoring Systems Blood Sugar Level Clinical Medicine Healthcare Providers Hyperglycemia Hypoglycemia Medical Device Medical Equipment Medical Technology Nasdaq 100 Platinum

    Related ETFs - A few ETFs which own one or more of the above listed Continuous Glucose Monitor stocks.

    Symbol Grade Name Weight
    EKG D First Trust Nasdaq Lux Digital Health Solutions ETF 9.62
    SNSR C Global X Internet of Things Thematic ETF 7.32
    EDOC D Global X Telemedicine & Digital Health ETF 6.83
    FDHT D Fidelity Digital Health ETF 5.48
    IHI C iShares U.S. Medical Devices ETF 4.69
    View all Continuous Glucose Monitor ETFs...
    Compare ETFs
    Compare EDOC to FDHT Compare EKG to SNSR Compare SNSR to FDHT

        Continuous Glucose Monitor Stocks Recent News

        Date Stock Title
        Apr 25 DXCM DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript
        Apr 25 DXCM Dexcom down 7% after hours despite quarterly beats, 2024 outlook updates
        Apr 25 DXCM Dexcom's profit beats estimates on strong glucose monitor demand
        Apr 25 DXCM DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
        Apr 25 DXCM DexCom Inc (DXCM) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
        Apr 25 DXCM Dexcom Plummets After Raising Its Sales Guidance For The Year — But Not Enough
        Apr 25 DXCM DexCom, Inc. 2024 Q1 - Results - Earnings Call Presentation
        Apr 25 DXCM DexCom Non-GAAP EPS of $0.32 beats by $0.05, revenue of $921M beats by $10.1M
        Apr 25 DXCM Dexcom Reports First Quarter 2024 Financial Results
        Apr 24 DXCM DexCom Q1 2024 Earnings Preview
        Apr 24 DXCM Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
        Apr 23 DXCM DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
        Apr 23 DXCM Boston Scientific, Dexcom and Edwards next as earnings season rolls on
        Apr 22 DXCM Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
        Apr 22 DXCM Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
        Apr 19 DXCM Even IBD 50 Medical Products Stocks Don't All Look Healthy In This Sick Market
        Apr 19 DXCM Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week
        Apr 19 DXCM 3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
        Related Industries: Diagnostics & Research Medical Devices
        Related Stock Lists: Blood Glucose Monitoring Diabetes Diabetes Mellitus Glucose Medical Monitoring Medicine Blood Test Endocrine System Endocrinology Glucose Monitoring Systems Blood Sugar Level Clinical Medicine Healthcare Providers Hyperglycemia Hypoglycemia Medical Device Medical Equipment Medical Technology Nasdaq 100 Platinum
        Continuous Glucose Monitor

        A Continuous Glucose Monitor (CGM) is a device that measures glucose levels in the body in real-time. It is typically worn on the body and can provide a continuous stream of glucose readings throughout the day and night. CGMs are used to help people with diabetes better manage their condition by providing more accurate and timely information about their glucose levels.

        Browse All Tags